window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug discovery

  • Artificial Intelligence,Drug discovery,Precision medicine,Research & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    February 24, 2026
  • Cell & Gene Therapy,Drug discovery,Technology and platforms

    MaxCyte launches 96-well electroporation platform for cell therapy discovery

    MaxCyte, Inc. has launched ExPERT DTx, a 96-well electroporation platform [...]

    February 24, 2026
  • Biotech,Central Nervous System,Clinical Development,Drug Development,Rare Diseases,Research & Development

    Lario receives $2.4M from MJFF and Wellcome to expand neuronal calcium channel research in CNS disorders

    Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]

    February 19, 2026
  • Biotech,Mergers & Acquisitions,Opthalmology,Research & Development,Technology and platforms

    Axol Bioscience acquires Newcells ophthalmology business to expand retinal organoid portfolio

    Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]

    February 19, 2026
  • Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development,Drug Development,Rare Diseases,Research & Development

    iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases

    iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]

    January 29, 2026
  • Artificial Intelligence,Clinical Development,Drug Development,Research & Development

    Soley Therapeutics study suggests live cell stress signals could reveal drug mechanisms

    Soley Therapeutics has published a peer-reviewed study describing a method [...]

    January 22, 2026
  • Biotech,Drug Development,Immunology,Research & Development

    Nucleome Therapeutics nominates first preclinical development candidate for inflammatory diseases

    Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

    January 8, 2026
  • Neurosciences,Rare Diseases,Research & Development

    Successful treatment for ALS could deliver billions in global value

    New research commissioned by Challenge Works and conducted by the [...]

    November 13, 2025
  • Genomics and sequencing,Partnerships & Funding,Research & Development,Technology and platforms

    Nucleome Therapeutics and Oxford University reveal genome structure at base pair resolution

    Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

    November 6, 2025
  • European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Enhanced Genomics extends Series A to $19m to advance autoimmune therapeutics pipeline

    Enhanced Genomics has secured an additional funding round, bringing its [...]

    September 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen
    Categories: Clinical Development, Infectious Diseases, Patient Centricity, Precision medicine
  • SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics
    Categories: Diagnostics, Oncology, Partnerships & Funding
  • Young adults in US, UK and Australia hit hardest by global mental health decline
    Categories: Clinical studies, Digital Health, Global health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top